Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 15;7(1):100021.
doi: 10.1016/j.rpth.2022.100021. eCollection 2023 Jan.

Hormonal therapies and venous thrombosis: Estrogen matters!

Affiliations

Hormonal therapies and venous thrombosis: Estrogen matters!

Laure Morimont et al. Res Pract Thromb Haemost. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure
(A) Association between normalized activated protein C sensitivity ratio data and relative risk of venous thromboembolism in women using combined oral contraceptives and (B) comparison of the impact of E4/DRSP versus that of EE/LNG and EE/DRSP on key coagulation markers. COC, combined oral contraceptive; CPA, cyproterone acetate; DRSP, drospirenone; DSG, desogestrel; E2, estradiol; E4, estetrol; EE, ethinylestradiol; LNG, levonorgestrel; nAPCsr, normalized activated protein C sensitivity ratio; NOMAC, nomegestrol acetate; RR, relative risk; SHBG, sex hormone-binding globulin; TFPI, tissue factor pathway inhibitor; VTE, venous thromboembolism.

References

    1. Stanczyk F.Z., Hapgood J.P., Winer S., Mishell D.R., Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2013;34:171–208. - PMC - PubMed
    1. Creinin M.D., Jensen J.T. Oral contraceptive generations—time to stop using a marketing myth to define nomenclature. Contraception. 2020;102:143–144. - PubMed
    1. Grandi G., Facchinetti F., Bitzer J. Confirmation of the safety of combined oral contraceptives containing oestradiol on the risk of venous thromboembolism. Eur J Contracept Reprod Health Care. 2022;27:83–84. - PubMed
    1. Gerard C., Arnal J.F., Jost M., Douxfils J., Lenfant F., Fontaine C., et al. Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause. Expert Rev Clin Pharmacol. 2022;15:121–137. - PubMed
    1. de Bastos M., Stegeman B.H., Rosendaal F.R., Vlieg A.V., Helmerhorst F.M., Stijnen T., et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014:CD010813. - PMC - PubMed

LinkOut - more resources